Cancer Prevention Research

Scope & Guideline

Shaping the dialogue on cancer prevention and public health.

Introduction

Welcome to the Cancer Prevention Research information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Cancer Prevention Research, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1940-6207
PublisherAMER ASSOC CANCER RESEARCH
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2008 to 2024
AbbreviationCANCER PREV RES / Cancer Prev. Res.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404

Aims and Scopes

Cancer Prevention Research focuses on the multifaceted approaches to cancer prevention, encompassing a wide range of biological, environmental, and behavioral factors. The journal aims to disseminate innovative research findings that contribute to understanding and mitigating cancer risk, promoting early detection, and improving preventive strategies.
  1. Biomarker Discovery and Application:
    The journal emphasizes the identification and validation of biomarkers that can aid in the early detection of cancer and assess individual risk factors. This includes genetic, epigenetic, and proteomic markers.
  2. Lifestyle and Dietary Interventions:
    Research on the roles of diet, exercise, and lifestyle modifications in cancer prevention is a core focus, exploring how these factors influence cancer risk and progression.
  3. Genetic and Environmental Risk Factors:
    The journal investigates the interplay between genetic predispositions and environmental exposures in cancer development, aiming to enhance risk stratification and personalized prevention strategies.
  4. Immunoprevention and Vaccination:
    A significant area of research is dedicated to immunoprevention strategies, including the development of vaccines and immunotherapies aimed at preventing cancer progression in high-risk populations.
  5. Community Engagement and Health Equity:
    The journal places importance on community-based approaches and health equity, studying how socioeconomic factors and access to care impact cancer prevention efforts.
  6. Clinical Trials and Translational Research:
    Cancer Prevention Research publishes findings from clinical trials that evaluate the efficacy of preventive interventions, aiming to translate research into practical applications for cancer prevention.
Recent publications in Cancer Prevention Research indicate a shift towards innovative and interdisciplinary approaches to cancer prevention. The following themes represent emerging areas of focus that are gaining traction among researchers.
  1. Microbiome Research and Cancer:
    The role of the microbiome in cancer development and prevention is increasingly recognized, with studies exploring how microbiota composition influences cancer risk and treatment responses.
  2. Precision Cancer Prevention:
    There is a growing emphasis on personalized prevention strategies, utilizing genomic and biomarker data to tailor interventions for individuals based on their unique risk profiles.
  3. Health Disparities and Social Determinants:
    Research addressing health disparities, particularly in underserved populations, is on the rise, focusing on how social determinants impact cancer risk and prevention efforts.
  4. Integration of Artificial Intelligence in Cancer Prevention:
    The use of AI and machine learning in analyzing large datasets for cancer risk prediction and prevention strategies is becoming more prevalent, indicating a trend toward data-driven approaches.
  5. Inflammation and Cancer Prevention:
    Emerging studies are increasingly focusing on the role of inflammation in cancer biology, investigating how anti-inflammatory strategies can be utilized for prevention.

Declining or Waning

While Cancer Prevention Research continues to evolve, certain themes appear to be diminishing in frequency or focus. This section highlights those areas that are losing prominence in recent publications.
  1. Traditional Chemoprevention Agents:
    Research on conventional chemopreventive agents, like certain NSAIDs or antioxidants, has seen a decline, possibly due to the increasing focus on precision medicine and targeted therapies.
  2. Single-Agent Studies:
    There is a noticeable reduction in studies focusing on single-agent interventions, as the field shifts towards more complex, multifactorial approaches to prevention.
  3. Basic Laboratory Studies Without Clinical Relevance:
    The journal has moved away from publishing basic science studies that do not have direct implications for clinical practice or public health, favoring research that bridges the gap between laboratory findings and real-world applications.
  4. Epidemiological Studies in Isolation:
    While epidemiological studies remain important, there is a trend towards integrating these findings with molecular and clinical data, reducing the emphasis on standalone epidemiological research.

Similar Journals

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Pioneering Research for Tomorrow's Treatments
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0889-8588Frequency: 6 issues/year

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, published by W B SAUNDERS CO-ELSEVIER INC, is a premier journal dedicated to advancing the fields of hematology and oncology. With its ISSN 0889-8588 and E-ISSN 1558-1977, this esteemed publication has been a cornerstone of clinical scholarship since its inception in 1987, providing comprehensive annual updates that bridge the gap between research and clinical practice. Known for its rigorous editorial standards and impactful contributions, the journal holds a respectable Q2 quartile classification in both hematology and oncology as of 2023, ranking it in the 50th percentile among its peers. Although it is not an open-access journal, the content is accessible to institutions and professionals worldwide. As the scope of the journal expands through 2024, it continues to attract an audience of researchers, healthcare professionals, and students who seek to stay informed on the latest advancements, treatment modalities, and groundbreaking studies in the fields of hematology and oncology.

CANCER CAUSES & CONTROL

Empowering Researchers with Critical Cancer Insights
Publisher: SPRINGERISSN: 0957-5243Frequency: 12 issues/year

Cancer Causes & Control, an esteemed journal within the field of Cancer Research and Oncology, is published by SPRINGER. Since its inception in 1990, this journal has dedicated itself to exploring the complex interplay between environmental, genetic, and lifestyle factors that contribute to cancer causation and control, aiming to inform public health initiatives and improve cancer prevention strategies. With an impressive Q2 rank in both its categories, the journal serves as a vital resource for researchers, professionals, and students seeking insights into the latest findings and methodologies in cancer epidemiology. Although there is no Open Access option, researchers can access valuable articles that reflect rigorous peer review and significant contributions to the field. The journal’s commitment to advancing knowledge related to cancer risks and management makes it an essential platform for disseminating impactful research and fostering collaboration among scholars worldwide.

Advances in Public Health

Bridging knowledge and practice in public health.
Publisher: HINDAWI LTDISSN: 2356-6868Frequency: 1 issue/year

Advances in Public Health is a distinguished open access journal dedicated to the dissemination of cutting-edge research in the field of public health, published by HINDAWI LTD. Since its inception in 2014, this journal has aimed to foster innovation and facilitate critical discourse on public health challenges, policies, and practices across the globe. With an ISSN of 2356-6868 and an E-ISSN of 2314-7784, it maintains a robust presence in the academic community, featuring prominently with a Scopus rank of #213/665 and proudly residing in the Q2 category within Public Health, Environmental, and Occupational Health as of 2023. Based in Egypt, and serving an international readership, Advances in Public Health provides a platform for researchers, professionals, and students to share their findings and insights, ultimately contributing to the improvement of health outcomes worldwide. Its open access format ensures that valuable research is available to a broader audience, promoting collaboration and knowledge sharing within the public health domain.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Advancing the Frontiers of Cancer Research.
Publisher: SPRINGERISSN: 0171-5216Frequency: 12 issues/year

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, published by Springer, is a prestigious peer-reviewed journal dedicated to advancing the fields of cancer research and clinical oncology. With an impact factor reflecting its significance within the academic community, the journal operates under a rigorous quality standard and offers a wealth of knowledge spanning from 1979 and continuing through 2025. With its comprehensive scope, it encompasses a wide array of topics including novel therapeutic strategies, clinical trials, and cutting-edge research methodologies, making it an essential resource for researchers, practitioners, and students alike. The journal’s category quartiles highlight its competitive edge, ranking Q2 in Cancer Research and Q1 in Medicine (miscellaneous) as of 2023. This positioning underscores its role at the forefront of oncology discourse. Through this journal, contributors and readers alike engage with impactful research that informs clinical practices and enhances patient care in oncology. Access to the journal’s content, although not open access, ensures curated and high-quality insights available to the academic and professional community.

Journal of the Egyptian National Cancer Institute

Bridging gaps in cancer knowledge for a healthier tomorrow.
Publisher: SPRINGERISSN: 1110-0362Frequency: 1 issue/year

Journal of the Egyptian National Cancer Institute, published by SPRINGER, serves as a vital platform for disseminating innovative research in the field of oncology and cancer research. With both ISSN 1110-0362 and E-ISSN 2589-0409, this Open Access journal has been committed to making significant contributions to the scientific community since its inception in 2005. Operating from its base in Egypt, it has established itself as an important resource for researchers, practitioners, and students alike, offering insights into contemporary issues and advancements in cancer care. Recognized in the 2023 category quartiles as Q3 in Cancer Research and Q3 in Oncology, the journal is positioned to impact the ongoing discourse in cancer treatment strategies and health policy. As it continues to publish peer-reviewed articles through available Open Access avenues, the Journal of the Egyptian National Cancer Institute remains dedicated to enhancing the knowledge base and collaborative efforts within the global cancer research community.

International Journal of Cancer Management

Driving collaboration in the fight against cancer.
Publisher: BRIEFLANDISSN: 2538-4422Frequency: 12 issues/year

The International Journal of Cancer Management is a distinguished publication dedicated to advancing knowledge and research in the fields of cancer management, oncology, pharmacology, and radiology. Published by BRIEFLAND in the Netherlands, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the latest developments in cancer care and treatment strategies. With an ISSN of 2538-4422 and an E-ISSN of 2538-497X, the journal features a range of peer-reviewed articles that cover diverse aspects of cancer management, reflecting its commitment to high-quality, impactful research. The journal ranks in the Q4 category for Cancer Research and Oncology and Q3 for both Pharmacology and Surgery in 2023, signifying its growing influence in the scientific community. Through its open access format, the International Journal of Cancer Management ensures that critical research findings are accessible to all, promoting collaboration and innovation in the battle against cancer. Researchers looking to share their findings or learn more about current trends will find this journal an invaluable addition to their professional toolkit.

CANCER SCIENCE

Pioneering discoveries in cancer biochemistry and genetics.
Publisher: WILEYISSN: 1347-9032Frequency: 12 issues/year

Cancer Science, an esteemed journal published by Wiley, stands at the forefront of oncology research, boasting an impressive impact factor and a classification in the Q1 category for its contributions in Cancer Research, Medicine, and Oncology as of 2023. Since its inception in 2003 and transitioning to an Open Access model in 2014, the journal has facilitated global dissemination of critical research findings, ensuring that vital information remains accessible to researchers, clinicians, and students alike. With its comprehensive scope covering cutting-edge discoveries in cancer biochemistry, genetics, and molecular biology, Cancer Science is recognized for its rigorous peer-review process and significant contributions to advancing our understanding of cancer. The journal, located at 111 River St, Hoboken, NJ, is an essential resource for anyone dedicated to improving treatment outcomes and pushing the boundaries of cancer research.

Oncology Letters

Empowering Oncology with Groundbreaking Discoveries
Publisher: SPANDIDOS PUBL LTDISSN: 1792-1074Frequency: 12 issues/year

Oncology Letters is a prominent academic journal dedicated to disseminating high-quality research in the fields of oncology and cancer research. Published by SPANDIDOS PUBL LTD and based in Greece, this journal has established a significant presence since its inception in 2010 and continues to contribute to the scientific community with a focus on both clinical and experimental oncology. Notably, it holds a respectable Q3 ranking in the categories of Cancer Research and Oncology as of 2023, highlighting its relevance and contribution to these critical fields. With a Scopus rank of #139/404 in Medicine – Oncology and #117/230 in Biochemistry, Genetics, and Molecular Biology – Cancer Research, Oncology Letters serves as a valuable platform for researchers, professionals, and students alike to explore emerging findings and innovative treatment approaches. Though it operates within a traditional subscription model, this journal prides itself on fostering accessible and impactful discourse in oncology, making it an essential resource for those committed to advancing cancer research and improving patient care.

Cancer Communications

Pioneering Discoveries in Cancer Communications
Publisher: WILEYISSN: Frequency: 12 issues/year

Cancer Communications, published by WILEY, is a leading open-access journal that has positioned itself at the forefront of cancer research and oncology since its inception in 2017. With an impressive HIndex reflective of its scholarly impact and recognized in the Q1 category for both Cancer Research and Oncology as of 2023, this journal consistently ranks in the top echelons of its field, specifically at Rank #16/404 and Rank #13/230 in their respective categories on Scopus. Cancer Communications aims to disseminate cutting-edge research findings, innovative methodologies, and significant advancements in cancer treatments, thereby fostering a deeper understanding of oncology among researchers, healthcare professionals, and students. The journal operates under an Open Access model since 2018, ensuring that vital research is accessible to a global audience, thus enhancing collaboration and knowledge sharing necessary to tackle one of the most pressing health challenges of our time. Located in Hoboken, NJ, United States, and with a strong commitment to scientific excellence, Cancer Communications remains an essential resource for anyone engaged in the fight against cancer.

JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY

Unraveling the Complexities of Toxicology and Pathology
Publisher: BEGELL HOUSE INCISSN: 0731-8898Frequency: 4 issues/year

JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, published by BEGELL HOUSE INC, serves as a vital platform for researchers and professionals engaged in the interdisciplinary fields of environmental health, pathology, and toxicology. With a history spanning from 1984 to the present, the journal is dedicated to disseminating high-quality research that explores the complexities of environmental threats to human health and their pathological implications. Its current ranking in the Q3 category across key areas including Health, Toxicology and Mutagenesis, Medicine (miscellaneous), and Pathology and Forensic Medicine underscores its relevance in the academic landscape. Despite not being an open-access journal, it remains an essential resource for those seeking to understand the impact of environmental factors on health outcomes. The journal's rigorous peer-review process and commitment to advancing knowledge make it an indispensable tool for students, researchers, and professionals striving to address pressing health and environmental challenges.